Benzinga's Top #PreMarket Gainers

Immunomedics, Inc. IMMU shares rose 29.77 percent to $2.79 in pre-market trading following announcement of interim Phase 2 Results with sacituzumab govitecan in lung cancers. Yingli Green Energy Hold. Co. Ltd. (ADR) YGE shares jumped 13.31 percent to $0.63 in pre-market trading. Yingli Green Energy reported a Q2 ADS loss of $0.53 on revenue of $438.1 million. Infinera Corp. INFN shares rose 2.15 percent to $20.95 in pre-market trading. Goldman Sachs downgraded Infinera from Neutral to Sell and lowered the price target from $24.00 to $19.00. Cerus Corporation CERS gained 0.38 percent to $5.22 in pre-market trading after surging 6.29 percent on Friday. KaloBios Pharmaceuticals Inc KBIO shares climbed 0.25 percent to $4 in pre-market trading after jumping 32.34 percent on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!